Skip to search formSkip to main contentSkip to account menu

tasimelteon

Known as: N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide, N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide, tasimeltéon 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

BMS 214778Hetlioz

Broader (2)

BenzofuransCyclopropanes
tasimelteon 20 MG Oral Capsule [Hetlioz]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes—Tasimelteon as an Example
This is the fourth in a series of columns discussing the rational and targeted development of drugs to affect specific central… 
Review
2016
Review
2016
Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014
Regulatory approval documents contain valuable information, often not published, to assess the drug–drug interaction (DDI… 
Review
2015
Review
2015
Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
Tasimelteon (Hetlioz®), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be… 
2015
2015
Re-engaging the health community around peace
2014
2014
Tasimelteon for Non-24-Hour Sleep–Wake Disorder
The melatonin receptor agonist tasimelteon has been approved to treat non-24 sleep–wake disorder in totally blind individuals… 
Review
2014
Review
2014
Melatonin agonists in the management of sleep disorders: A focus on ramelteon and tasimelteon
Melatonin agonists have become an area of interest in the treatment of sleep disorders. This article reviews the available data… 
2014
2014
TASIMELTEON: A NOVEL DRUG IN NON-24 HOURS SLEEP WAKE DISORDER
Free-running type or non 24 hour sleep wake disorder is a rare but chronic circadian rhythm sleep disorder (CRSD) that disrupts… 
2012
2012
Alzheimer's Disease: Focus on the Neuroprotective Role of Melatonin
Alzheimer’s disease (AD) is characterized by a progressive loss of memory and cognitive function, and by behavioural and sleep… 
2010
2010
Chronophysiology of Melatonin: Therapeutical Implications
Normal circadian rhythms are synchronized to a regular 24 hr environmental light/dark cycle. Both the su- prachiasmatic nucleus… 
2009
2009
Health before profits? Learning from Thailand's experience
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)